Expression of prolactin and its receptor in human breast carcinoma

Endocrinology

Volumn 138, Issue 12, 1997, Pages 5555-5560

  Reynolds, Carol ^a   Montone, Kathleen T ^a   Powell, Colleen M ^a   Tomaszewski, John E ^a   Clevenger, Charles V ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; PROLACTIN RECEPTOR;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; FEMALE; GROWTH REGULATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROLACTIN RELEASE;

EID: 0030670683     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.12.5605     Document Type: Article

References (37)

1. Manni A, Wright C, Davis G, Glenn J, Joehl R, Feil P 1986 Promotion by prolactin of the growth of human breast neoplasms cultured in vitro in the soft agar clonogenic assay. Cancer Res 46:1669-1672
2. Malarkey WB, Kennedy M, Allred LE, Milo G 1983 Physiological concentrations of prolactin can promote the growth of human breast tumor cells in culture. J Clin Endocrinol Metab 56:673-677
3. Biswas R, Vonderhaar BK 1987 Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture. Cancer Res 47:3509-3514
4. Cunningham BC, Henner DJ, Wells JA 1990 Engineering human prolactin to bind to the human growth hormone receptor. Science 247:1461-1465
5. Wells JA, Cunningham BC, Fuh G, Lowman HB, Bass SH, Mulkerrin MG, Ultsch M, DeVos AM 1993 The molecular basis for growth hormone receptor interactions. Recent Prog Horm Res 48:253-275
6. Kelly PA, Ali S, Rozakis M, Goujon L, Nagano M, Postel-Vinay MC, Pelligrini I, Gould D, Djiane J, Edery M, Finidori J 1993 The growth hormone/prolactin receptor family. Recent Prog Horm Res 48:123-164
7. Shiu RP, Murphy LC, Tsuyuki D, Myal Y, Lee-Wing M, Iwasiow B 1987 Biological actions of prolactin in human breast cancer. Recent Prog Horm Res 43:277-303
8. Fisher B, Redmond C, Fisher ER, Caplan R 1988 Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol 6:1076-1087
9. Lupu R, Lippman ME 1993 The role of erbB2 signal transduction pathways in human breast cancer. Breast Cancer Res Treat 27:83-93
10. Klijn JG, Berns EMJJ, Foekens JA 1993 Prognostic factors and response to therapy in breast cancer. Cancer Surv 18:165-198
11. Holdaway IM, Friesen HG 1977 Hormone binding by human mammary carcinoma. Cancer Res 37:1946-1952
12. Partridge RK, Hahnel R 1979 Prolactin receptors in human breast carcinoma. Cancer 43:643-646
13. Turcot-Lemay L, Kelly PA 1982 Prolactin receptors in human breast tumors. J Natl Cancer Inst 68:381-383
14. Bonneterre J, Peyrat JPH, Vanderwalle B, Beuscart R, Vie MC, Cappelaere P 1982 Prolactin receptors in human breast cancer. Eur J Cancer Clin Oncol 18:1157-1162
15. Clevenger CV, Chang W, Ngo W, Pasha TLM, Montone KT, Tomaszewski JE 1995 Expression of prolactin and prolactin receptor in human breast carcinoma. Am J Pathol 146:695-705
16. Fields K, Kulig E, Lloyd RV 1993 Detection of prolactin messenger RNA in mammary and other normal and neoplastic tissues by polymerase chain reaction. Lab Invest 68:354-360
17. Ginsburg E, Vonderhaar BK 1995 Prolactin synthesis and secretion by human breast cancer cells. Cancer Res 55:2591-2595
18. Fuh G, Wells JA 1995 Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J Biol Chem 270:13133-13137
19. Montone KT, Friedman H, Hodinka RL, Hicks DG, Kant JA, Tomaszewski JE 1992 In situ hybridization for Epstein-Barr virus Not 1 repeats in posttransplant lymphoproliferative disorder. Mod Pathol 5:292-302
20. Unger ER, Brigati DJ, Chenggis ML, et al 1988 Automation of in situ DNA hybridization: application of the capillary action robotic workstation. J Histotechnol 11:253-258
21. Katoh M, Raguet S, Zachwieja J 1987 Hepatic prolactin receptors in the rat: characterization using monoclonal antireceptor antibodies. Endocrinology 120:739-749
22. Thorpe SM 1988 Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance. Acta Oncol 27:1-19
23. Chamness GC, McGuire WL 1975 Scatchard plots: common errors in correction and interpretation. Steroids 26:538-542
24. Abbott Laboratories 1990 Immunocytochemical assay for the detection of human estrogen receptor and progesterone receptor. Abbott, North Chicago
25. Shiu RP, Iwasiow BM 1985 Prolactin-inducible protein in human breast cancer cells. J Biol Chem 260:11307-11313
26. Welsch CW, Nagasawa H 1977 Prolactin and murine mammary tumorigenesis: a review. Cancer Res 37:951-963
27. Peyrat JP, Vennin PH, Bonneterre J, Hecquet B, Vandewalle B, Kelly P, Dijane J 1984 Effect of bromocriptine treatment on prolactin and steroid receptor levels in human breast cancer. Eur J Cancer Clin Oncol 20:1363-1367
28. Heuson JC, Coune A, Staquet M 1972 Clinical trial of 2-BR-alpha-ergocryptine (CB154) in advanced breast cancer. Eur J Cancer 8:155-156
29. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW 1996 Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17:639-661
30. Giss BJ, Walker AM 1985 Mammotroph autoregulation: intracellular fate of internalized prolactin. Mol Cell Endocrinol 42:259-267
31. Clevenger CV, Russell DH, Appasamy PM, Prystowsky MB 1990 Regulation of IL2-driven T-lymphocyte proliferation by prolactin. Proc Natl Acad Sci USA 87:6460-6464
32. Ellis LA, Mastro AM, Picciano MF 1996 Milk-borne prolactin and neonatal development. J Mammary Gland Biol Neoplasia 1:259-269
33. Lkhider M, Delpal S, Bousquet MO 1996 Rat PRL in serum, milk, and mammary tissue: characterization and intracellular localization. Endocrinology 137:4969-4979
34. Gellersen B, Kempf R, Telgmann R, DiMattia GE 1994 Nonpituitary human prolactin gene transcription is independent of pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol 8:356-373
35. Berwaer M, Martial JA, Davis JRE 1994 Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene. Mol Endocrinol 8:635-642
36. Ferrara N, Clapp C, Weiner R 1991 The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129:896-900
37. Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI 1993 The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133:1292-1299